Fee-For-Service Billing Information for Naloxone
Generic Naloxone - FFS covers generic naloxone without prior authorization. Claims for naloxone should be submitted via standard billing processes.
 
Nasal Atomization Device - FFS will make payment for the nasal atomization device used to administer naloxone intranasally. Providers may submit pharmacy claims for the nasal atomization device using NDC 06011-2313-06. 
 

Pharmacies will need to contact each MCO individually to obtain information about their billing procedures.

See Department of Health website for more information on Naloxone Standing Order.